loadpatents
name:-0.04074501991272
name:-0.029753923416138
name:-0.014111995697021
Guba; Wolfgang Patent Filings

Guba; Wolfgang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guba; Wolfgang.The latest application filed is for "ethynyl derivatives".

Company Profile
24.52.55
  • Guba; Wolfgang - Muellheim DE
  • Guba; Wolfgang - Basel CH
  • Guba; Wolfgang - Mullheim DE
  • Guba; Wolfgang - Mulheim DE
  • Guba; Wolfgang - Muelheim DE
  • Guba; Wolfgang - Mueliheim DE
  • - Muelheim DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ethynyl Derivatives
App 20210269452 - Biemans; Barbara ;   et al.
2021-09-02
BACE1 inhibitors
Grant 11,034,687 - Bartels , et al. June 15, 2
2021-06-15
Ethynyl derivatives
Grant 11,034,699 - Biemans , et al. June 15, 2
2021-06-15
Pyridine And Pyrazine Derivatives As Preferential Cannabinoid 2 Agonists
App 20210115027 - Ametamey; Simon M. ;   et al.
2021-04-22
Pyridyl-triazabicycles
Grant 10,829,500 - Bartels , et al. November 10, 2
2020-11-10
Bace1 Inhibitors
App 20200308166 - Bartels; Bjoern ;   et al.
2020-10-01
BACE1 inhibitors
Grant 10,723,729 - Bartels , et al.
2020-07-28
BACE1 inhibitors
Grant 10,696,691 - Bartels , et al. June 30, 2
2020-06-30
Pyridyl-triazabicycles
App 20190352312 - Bartels; Bjoern ;   et al.
2019-11-21
Bace1 Inhibitors
App 20190337936 - Bartels; Bjoern ;   et al.
2019-11-07
[1,2,3]triazolo[4,5-d]pyrimidine derivatives
Grant 10,457,684 - Gobbi , et al. Oc
2019-10-29
[1,2,3]triazolo[4,5-D]pyrimidine derivatives
Grant 10,457,686 - Gobbi , et al. Oc
2019-10-29
[1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor
Grant 10,457,685 - Gobbi , et al. Oc
2019-10-29
[1,2,3]triazolo[4,5-D]pyrimidine derivatives
Grant 10,450,321 - Gobbi , et al. Oc
2019-10-22
Pyridyl-triazabicycles
Grant 10,414,780 - Bartels , et al. Sept
2019-09-17
Bace1 Inhibitors
App 20190270757 - Bartels; Bjoern ;   et al.
2019-09-05
BACE1 inhibitors
Grant 10,399,969 - Bartels , et al. Sep
2019-09-03
Novel [1,2,3]triazolo[4,5-d]pyrimidine Derivatives
App 20190127386 - GOBBI; Luca ;   et al.
2019-05-02
Novel [1,2,3]triazolo[4,5-d]pyrimidine Derivatives
App 20190127385 - Gobbi; Luca ;   et al.
2019-05-02
[1,2,3]triazolo[4,5-d]pyrimidine Derivatives With Affinity For The Type-2 Cannabinoid Receptor
App 20190127384 - GOBBI; Luca ;   et al.
2019-05-02
Novel [1,2,3]triazolo[4,5-d]pyrimidine Derivatives
App 20190127383 - GOBBI; Luca ;   et al.
2019-05-02
Ethynyl Derivatives
App 20190119290 - Biemans; Barbara ;   et al.
2019-04-25
BACE1 inhibitors
Grant 10,246,468 - Bartels , et al.
2019-04-02
Ethynyl derivatives
Grant 10,189,848 - Biemans , et al. Ja
2019-01-29
Bace1 Inhibitors
App 20190002476 - Bartels; Bjoern ;   et al.
2019-01-03
Bace1 Inhibitors
App 20180319787 - Bartels; Bjoern ;   et al.
2018-11-08
Pyridyl-triazabicycles
App 20180312528 - Bartels; Bjoern ;   et al.
2018-11-01
Ethynyl derivatives
Grant 10,065,956 - Biemans , et al. September 4, 2
2018-09-04
BACE1 inhibitors
Grant 10,047,081 - Bartels , et al. August 14, 2
2018-08-14
Pyridyl-triazabicycles
Grant 10,047,102 - Bartels , et al. August 14, 2
2018-08-14
Pyridyl-triazabicycles
App 20180194779 - Bartels; Bjoern ;   et al.
2018-07-12
Ethynyl Derivatives
App 20180134721 - Biemans; Barbara ;   et al.
2018-05-17
BACE1 inhibitors
Grant 9,920,072 - Bartels , et al. March 20, 2
2018-03-20
Bace1 Inhibitors
App 20180057485 - Bartels; Bjoern ;   et al.
2018-03-01
2,2,2-trifluoroethyl-thiadiazines
Grant 9,896,438 - Anselm , et al. February 20, 2
2018-02-20
Ethynyl Derivatives
App 20180002333 - BIEMANS; Barbara ;   et al.
2018-01-04
Bace1 Inhibitors
App 20170334930 - Bartels; Bjoern ;   et al.
2017-11-23
2,2,2-trifluoroethyl-thiadiazines
App 20170226091 - ANSLEM; Lilli ;   et al.
2017-08-10
Ethynyl derivatives
Grant 9,725,416 - Vieira , et al. August 8, 2
2017-08-08
Ethynyl derivatives
Grant 9,695,128 - Biemans , et al. July 4, 2
2017-07-04
Ethynyl derivatives
Grant 9,676,732 - Biemans , et al. June 13, 2
2017-06-13
Ethynyl Derivatives
App 20170114028 - Biemans; Barbara ;   et al.
2017-04-27
5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines
Grant 9,605,006 - Guba , et al. March 28, 2
2017-03-28
Ethynyl Derivatives
App 20170008854 - Biemans; Barbara ;   et al.
2017-01-12
BACE1 inhibitors
Grant 9,540,397 - Bartels , et al. January 10, 2
2017-01-10
Ethynyl Derivatives
App 20160362383 - Vieira; Eric ;   et al.
2016-12-15
5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines
App 20160318952 - Guba; Wolfgang ;   et al.
2016-11-03
Ethynyl Derivatives
App 20160207890 - BIEMANS; Barbara ;   et al.
2016-07-21
Arlethynyl derivatives
Grant 9,315,498 - Green , et al. April 19, 2
2016-04-19
Bace1 Inhibitors
App 20160102105 - Bartels; Bjoern ;   et al.
2016-04-14
1,4 oxazines as BACE1 and/or BACE2 inhibitors
Grant 9,242,943 - Andreini , et al. January 26, 2
2016-01-26
Fluoro-[1,3]oxazines As Bace1 Inhibitors
App 20150376172 - Guba; Wolfgang ;   et al.
2015-12-31
Ethynyl compounds useful for treatment of CNS disorder
Grant 8,933,094 - Green , et al. January 13, 2
2015-01-13
1,4,5,6-tetrahydro-pyrimidin-2-ylamine Compounds
App 20140336208 - Banner; David ;   et al.
2014-11-13
1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
Grant 8,815,881 - Banner , et al. August 26, 2
2014-08-26
1,4-oxazepines as BACE1 and/or BACE2 inhibitors
Grant 8,748,418 - Gabellieri , et al. June 10, 2
2014-06-10
Arlethynyl Derivatives
App 20140155602 - Green; Luke ;   et al.
2014-06-05
Positive allosteric modulators (PAM)
Grant 8,716,316 - Green , et al. May 6, 2
2014-05-06
2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
Grant 8,673,894 - Banner , et al. March 18, 2
2014-03-18
Ethynyl Compounds Useful For Treatment Of Cns Disorder
App 20140073638 - Green; Luke ;   et al.
2014-03-13
2,5,6,7-Tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
App 20140045820 - Banner; David ;   et al.
2014-02-13
Arylethynyl derivatives
Grant 08618296 -
2013-12-31
Arylethynyl derivatives
Grant 8,618,296 - Green , et al. December 31, 2
2013-12-31
Ethynyl compounds useful for treatment of CNS disorders
Grant 8,586,581 - Green , et al. November 19, 2
2013-11-19
Arylethynyl Derivatives
App 20130274464 - Green; Luke ;   et al.
2013-10-17
Arylethynyl derivatives
Grant 8,513,273 - Green , et al. August 20, 2
2013-08-20
3-amino-5-phenyl-56-dihydro-2h-[1,4]oxazines
App 20130196984 - Andreini; Matteo ;   et al.
2013-08-01
Arylethynyl Derivatives
App 20130178456 - Green; Luke ;   et al.
2013-07-11
Positive Allosteric Modulators (pam)
App 20130131056 - Green; Luke ;   et al.
2013-05-23
Arylethynyl derivatives
Grant 8,420,661 - Green , et al. April 16, 2
2013-04-16
2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides
Grant 8,389,513 - Banner , et al. March 5, 2
2013-03-05
Positive allosteric modulators (PAM)
Grant 8,389,536 - Green , et al. March 5, 2
2013-03-05
1,4-oxazepines As Bace1 And/or Bace2 Inhibitors
App 20120238548 - Gabellieri; Emanuele ;   et al.
2012-09-20
3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
App 20120214806 - Andreini; Matteo ;   et al.
2012-08-23
1,4 Oxazines As Bace1 And/or Bace2 Inhibitors
App 20120184540 - Andreini; Matteo ;   et al.
2012-07-19
3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
Grant 8,188,079 - Andreini , et al. May 29, 2
2012-05-29
1,4,5,6-tetrahydro-pyrimidin-2-ylamine Compounds
App 20120035195 - Banner; David ;   et al.
2012-02-09
2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine Or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine Compounds
App 20110312937 - Banner; David ;   et al.
2011-12-22
Arylethynyl derivatives
App 20110251169 - Green; Luke ;   et al.
2011-10-13
4,5-dihydro-oxazol-2-yl amine derivatives
Grant 7,989,449 - Andreini , et al. August 2, 2
2011-08-02
Ethynyl Compounds Useful For Treatment Of Cns Disorders
App 20110152257 - Green; Luke ;   et al.
2011-06-23
2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides
App 20110144097 - Banner; David ;   et al.
2011-06-16
Positive Allosteric Modulators (pam)
App 20110098313 - Green; Luke ;   et al.
2011-04-28
3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
App 20110046122 - Andreini; Matteo ;   et al.
2011-02-24
Amide derivatives as somatostatin receptor 5 antagonists
Grant 7,772,253 - Binggeli , et al. August 10, 2
2010-08-10
Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
Grant 7,645,753 - Binggeli , et al. January 12, 2
2010-01-12
4,5-dihydro-oxazol-2-yl Amine Derivatives
App 20090209529 - Andreini; Matteo ;   et al.
2009-08-20
Benzodioxole derivatives
Grant 7,576,088 - Alanine , et al. August 18, 2
2009-08-18
Benzooxazole, Oxazolopyridine, Benzothiazole And Thiazolopyridine Derivatives
App 20090163517 - Binggeli; Alfred ;   et al.
2009-06-25
Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity
Grant 7,323,466 - Bentley , et al. January 29, 2
2008-01-29
Aminothiazole derivatives
Grant 7,253,197 - Guba , et al. August 7, 2
2007-08-07
Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
App 20070093521 - Binggeli; Alfred ;   et al.
2007-04-26
Amide derivatives as somatostatin receptor 5 antagonists
App 20060276508 - Binggeli; Alfred ;   et al.
2006-12-07
Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
App 20060205718 - Binggeli; Alfred ;   et al.
2006-09-14
New morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity
App 20060178510 - Bentley; Jonathan Mark ;   et al.
2006-08-10
Benzodioxole derivatives
App 20050143373 - Alanine, Alexander ;   et al.
2005-06-30
Benzodioxole derivatives
Grant 6,900,227 - Alanine , et al. May 31, 2
2005-05-31
Novel pyrrolyl-thiazole derivatives
App 20040147572 - Guba, Wolfgang ;   et al.
2004-07-29
Benzodioxole derivatives
App 20040142922 - Alanine, Alexander ;   et al.
2004-07-22
Aminothiazole derivatives
App 20040038990 - Guba, Wolfgang ;   et al.
2004-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed